anidulafungin has been researched along with Infant, Premature, Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, DK; Cohen-Wolkowiez, M; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, S; Livermore, J; Petraitiene, R; Petraitis, V; Sharp, A; Walsh, TJ; Warn, PA | 1 |
| Revankar, SG; Sobel, JD | 1 |
2 other study(ies) available for anidulafungin and Infant, Premature, Diseases
| Article | Year |
|---|---|
Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Disease Models, Animal; Echinocandins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Meningitis, Fungal; Meningoencephalitis; Monte Carlo Method; Rabbits; Treatment Outcome | 2012 |
Echinocandins--first-choice or first-line therapy for invasive candidiasis?
Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Peptides, Cyclic | 2007 |